Effects of human growth hormone in critically ill nonseptic patients
- 1 April 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 23 (4) , 665-673
- https://doi.org/10.1097/00003246-199504000-00014
Abstract
To study the effects of growth hormone administration on insulin-like growth factor I concentration, nitrogen balance, and fuel utilization, and to study its safety in critically ill nonseptic patients. Prospective, randomized, placebo-controlled trial. Medical intensive care unit of a university hospital. Eighteen critically ill nonseptic patients were studied for 8 days after admission. Growth hormone (0.1 mg/kg/day) or placebo was administered as a continuous intravenous infusion on the second, third, and fourth days after admission. The study period was 8 days. Plasma hormone concentrations were measured every 6 hrs and average daily values were calculated. The 24-hr urinary nitrogen and 3-methylhistidine excretion were measured. Indirect calorimetry was used to calculate fuel utilization. Insulin-like growth factor I concentrations increased in the treatment group from subnormal to normal values and remained increased despite discontinuation of growth hormone treatment (p = .02). Nitrogen balance differed between the groups upon admission: growth hormone group (3.9 +/- 4.1 g/day) vs. controls (13.8 +/- 5.4 g/day), but improved with growth hormone. This finding appeared independent of the imbalance between the groups. The 3-methylhistidine excretion was not different between the groups and did not change during growth hormone administration. Free fatty acids and glycerol concentrations increased during growth hormone treatment, but calculated fuel utilization did not change. During growth hormone treatment, insulin concentrations increased, due to the increased administration of insulin necessary for glycemic control. Side effects other than hyperglycemia were not observed. Growth hormone administration in a heterogeneous group of critically ill nonseptic patients resulted in normalization of insulin-like growth factor I levels, even after cessation of growth hormone treatment. Nitrogen balance improved, but this change was transient. Hence, growth hormone affects nitrogen balance, probably partly independent of insulin-like growth factor I.Keywords
This publication has 38 references indexed in Scilit:
- Effects of Recombinant Human Growth Hormone in Patients With Severe SepsisAnnals of Surgery, 1992
- Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormoneJournal of Surgical Research, 1991
- Catabolic IllnessNew England Journal of Medicine, 1991
- The Effect of Growth Hormone on Weight Gain and Pulmonary Function in Patients with Chronic Obstructive Lung DiseaseChest, 1991
- Improvement of Septic Syndrome after Administration of Recombinant Human Growth Hormone (rhGH)?Published by Wolters Kluwer Health ,1991
- Use of Human Growth Hormone Combined with Nutritional Support in a Critical Care UnitJournal of Parenteral and Enteral Nutrition, 1990
- Metabolic effects of recombinant human growth hormone: Isotopic studies in the postabsorptive state and during total parenteral nutritionBritish Journal of Surgery, 1990
- Insulinlike Growth Factor 1 Production Is Inhibited in Human SepsisArchives of Surgery, 1988
- Metabolie Effects of Recombinant Human Growth Hormone in Patients Receiving Parenteral NutritionAnnals of Surgery, 1988
- The link between nutritional status and clinical outcome: can nutritional intervention modify it?The American Journal of Clinical Nutrition, 1988